Clinical Trials Browser

NETWORK × pazopanib × Clear all

NCT01566747 2021-12-23

Second-line Pazopanib Renal Cell Carcinoma (RCC) Study. CTRIAL-IE (ICORG) 10-01, V5

Phase 2 Completed

Carcinoma, Renal Cell